@teanijarv Profile picture

Toomas Erik Anijärv 🇪🇪

@teanijarv

PhD student at @lunduniversity @biofinder_study 🇸🇪 #mri #alzheimersdisease | Adjunct Fellow at the Thompson Institute of @usceduau 🇦🇺 #eeg #ketamine

Joined August 2016
Similar User
Alicia Campbell photo

@allyneuro

Shiang Hu photo

@BraitLab

ainiah photo

@_ainiah_

Toomas Erik Anijärv 🇪🇪 Reposted

📢The CHMP recommends authorising a new treatment for early #AlzheimersDisease in the EU. Leqembi is intended for treatment of mild dementia and cognitive impairment in a restricted patient population with a specific genetic make-up. 👉 ema.europa.eu/en/news/leqemb…

Tweet Image 1

Toomas Erik Anijärv 🇪🇪 Reposted

Cortical maps manifest hemispheric asymmetry in various forms and scales. Our attempt to unveil them through 🧠 eigenmodes: doi.org/10.1101/2024.1… Work led by Alicia Milloz✨

Tweet Image 1

Check out @allyneuro ‘s first paper, part of her PhD on the neurophysiological mechanisms of sustained attention and aging!

🧠 Exciting new findings from our study on brain function and ageing! We explored the relationship between brain oscillations and sustained attention in healthy older adults using resting-state EEG data. Here’s what we found: 🧵👇



Toomas Erik Anijärv 🇪🇪 Reposted

Interested in combining neuroimaging and multiomics in AD? Check out our new review on this topic, just published in Cell Reports Medicine. We focus on integration with amyloid- and tau-PET and all the challenges that come with it. w/ @NiklasMattsson4 cell.com/cell-reports-m…


Toomas Erik Anijärv 🇪🇪 Reposted

Big thanks to the BioFINDER team for two great days! During our workshop we sharpened our visions for the future, optimized our database structure and learnt from the clinicians how different clinical assessments are done.

Tweet Image 1

Toomas Erik Anijärv 🇪🇪 Reposted

🚨Publication in @JAMA_current 🚨 Blood biomarkers to detect Alzheimer’s disease in primary and secondary care, published today in JAMA led by @SebastianPalmqv: jamanetwork.com/journals/jama/…


Toomas Erik Anijärv 🇪🇪 Reposted

The figure we all have to learn by heart: The updated Lancet Commission on potentially modifiable risk factors for dementia. #AAIC24

Tweet Image 1

Toomas Erik Anijärv 🇪🇪 Reposted

My first paper, entitled “CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer’s disease”, has been published in Alzheimer’s & Dementia @alzdemjournals! Thread 👇🏽


Toomas Erik Anijärv 🇪🇪 Reposted

I am hiring a research technician to help process and analyze multimodal neuroimaging data. Please RT!! * Great opportunity to gain research experience pre-PhD * Access to exciting data * Opportunities for independent projects Apply here: lu.varbi.com/en/what:job/jo…


Super proud to be #Estonian as we are again one step closer to medicine 4.0. Besides different health risks, I also now know I’m 2.51% neanderthal and my ancestry reaches even Asia. nature.com/articles/d4158…


Toomas Erik Anijärv 🇪🇪 Reposted

🚨Paper alert Led by PhD student @SEMastenbroek “Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology” now published in @NatureComms ! nature.com/articles/s4146… We found a novel brainstem-first Lewy body subtype 👇


Toomas Erik Anijärv 🇪🇪 Reposted

🚨New publication out in @NatureComms led by @karlssonlinda1! We introduce CSF reference proteins: a way to account for the non-disease related signal in CSF protein levels that varies between individuals and affects biomarker performance. doi.org/10.1038/s41467… Detailed 🧵👇

🚨New preprint!! biorxiv.org/content/10.110… Led by PhD student @karlssonlinda1, we reveal a confounding signal in CSF proteomics data and present a new method to address it! Our method results in better biomarkers and, without it, spurious findings can arise. Check out this thread👇



Toomas Erik Anijärv 🇪🇪 Reposted

Todays lunch seminar offered many captivating talks! We learned by @teanijarv the impact of asymmetrical #tau aggregation in #AD, by Srisaiyini Kidnapillai about the current advances in glia to #interneurons #reprogramming, and by Filip Fredlund how #MHCII impact #PD pathology.

Tweet Image 1

Toomas Erik Anijärv 🇪🇪 Reposted

Wonderful summary by Hanny Le from our team documenting EEG spectral signature similarities and differences amongst the available psychedelics. Helpful guidance for research and mechanistically informed development pubmed.ncbi.nlm.nih.gov/38570038/


Toomas Erik Anijärv 🇪🇪 Reposted

‼️ Postdoc ad // Please RT/circulate ‼️ Are you interested in * Big euroimaging and multi-omic data? * Neurodegenerativ disease? The @biofinder_study is looking for a talented postdoc to sink their teeth into some rare and exciting data! Apply here: lu.varbi.com/en/what:job/jo…


Toomas Erik Anijärv 🇪🇪 Reposted

❗️Publication❗️ Head-to-head comparison between a highly accurate plasma biomarker and FDA-approved and clinically used CSF biomarkers 🩸#ptau217 is clinically comparable or superior to CSF biomarkers to detect #Alzheimer's pathologies @NatureMedicine nature.com/articles/s4159…


Just finished writing my annual review of my work and adventures during 2023. Long story short, I travelled a lot, moved to Sweden, and started a PhD! toomaserikanijarv.com/blog/2023-star… #PhD #phdvoice #AcademicChatter


Toomas Erik Anijärv 🇪🇪 Reposted

‼️New preprint‼️ 🔗Led by PhD student @SEMastenbroek, we unveil three different progression patterns of Lewy body pathology. Disease progression modeling of: * Postmortem Lewy-type α-synuclein data from 10 🧠 regions * N=814 donors 👇👇👇 biorxiv.org/content/10.110…


Toomas Erik Anijärv 🇪🇪 Reposted

Are you interested in Alzheimer's disease and other dementias, with specific interest in genetics🧬? Would you like to be part of a team that does cutting-edge research? We have a post-doc (lu.varbi.com/en/what:job/jo…) and a PhD (lu.varbi.com/what:job/jobID…) position available!


Just participated in this 5-day fMRI workshop at @MGHMartinos in Boston, USA - definitely recommend it!

Tweet Image 1

United States Trends
Loading...

Something went wrong.


Something went wrong.